Evolution of FIB-4 score in SpA and PsA patients taking anti-TNF or anti-IL17.

Verhoeven, Frank; Prati, Clément; Di Martino, Vincent; Thevenot, Thierry; Demougeot, Céline; Wendling, Daniel; Weil-Verhoeven, Delphine.

Afiliação

Verhoeven F; Department of Rheumatology, CHRU of Besançon, Besançon, France; Université de Franche-Comté, EFS, Inserm, UMR RIGHT, 25000 Besançon, France. Electronic address: fverhoeven@chu-besancon.fr.
Prati C; Department of Rheumatology, CHRU of Besançon, Besançon, France; Université de Franche-Comté, EFS, Inserm, UMR RIGHT, 25000 Besançon, France.
Di Martino V; Université de Franche-Comté, EFS, Inserm, UMR RIGHT, 25000 Besançon, France; Department of Hepatology, CHRU of Besançon, Besançon, France.
Thevenot T; Université de Franche-Comté, EFS, Inserm, UMR RIGHT, 25000 Besançon, France; Department of Hepatology, CHRU of Besançon, Besançon, France.
Demougeot C; Université de Franche-Comté, EFS, Inserm, UMR RIGHT, 25000 Besançon, France.
Wendling D; Department of Rheumatology, CHRU of Besançon, Besançon, France; Université de Franche-Comté, EFS, Inserm, UMR RIGHT, 25000 Besançon, France.
Weil-Verhoeven D; Université de Franche-Comté, EFS, Inserm, UMR RIGHT, 25000 Besançon, France; Department of Hepatology, CHRU of Besançon, Besançon, France.

Joint Bone Spine ; 91(6): 105763, 2024 Jul 29.

Article em En | MEDLINE | ID: mdl-39084400